Non‐clinical safety evaluation of single and repeated intramuscular administrations of MAGE‐A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys-Reference-Cited by-同舟云学术

Non‐clinical safety evaluation of single and repeated intramuscular administrations of MAGE‐A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys

Published:2014-09-12 Issue:7 Volume:35 Page:717-728
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J. Appl. Toxicol.

Author:

Destexhe Eric¹,Grosdidier Emilie²,Baudson Nathalie¹,Forster Roy²,Gerard Catherine¹,Garçon Nathalie¹,Segal Lawrence¹

Affiliation:

1. GlaxoSmithKline Vaccines 1330 Rixensart/Wavre Belgium

2. CiToxLAB France 27005 Evreux France

Funder

GlaxoSmithKline Vaccines

Publisher

Wiley

Subject

Toxicology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jat.3025

Reference48 articles.

1. Vaccines and Immunotherapeutics for the Treatment of Malignant Disease

2. Vaccine-Induced CD4+T Cell Responses to MAGE-3 Protein in Lung Cancer Patients

3. Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming

4. Basic local alignment search tool

5. Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunopharmacology and Immunotoxicology Assessment of Vaccines and Adjuvants;Reference Module in Biomedical Sciences;2024

2. Immunological and functional aspects of MAGEA3 cancer/testis antigen;Advances in Protein Chemistry and Structural Biology;2021

3. Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909;International Journal of Toxicology;2019-05

4. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg;Protein & Peptide Letters;2018-01-09

5. Signal management in pharmacovigilance and human risk assessment of CpG 7909, integrating embryo-fetal and post-natal developmental toxicity studies in rats and rabbits;Reproductive Toxicology;2018-01